Home » Drug Delivery » Injectable Drug Delivery » Self Injectable Specialty Drugs to 2022

Self Injectable Specialty Drugs to 2022


self injectable specialty drugs   Self Injectable Specialty Drugs • Published September 2015  •  Catalog no. SSD333R  •  Price US $3,850



Increases in life expectancy are expected to result in a growing number of patients diagnosed with chronic conditions. To counteract the financial and logistical implications of this trend, pressure from public health and managed care organizations will place a premium on therapeutic self-administration    Specialty Injectable formulation and packaging decisions are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships.

Bar_Graph Self Injectables Report Brochure (Download PDF)

Blue document Self Injectables Report Order Form (Download PDF)


 Self Injectable Specialty Drugs – What You Will Learn

• What are the currently marketed specialty injectable drugs intended for patient self administration?
• What are the therapeutic demand drivers for self-injectable specialty drugs and what are their growth prospects?
• What are the key formulation and packaging factors and market development issues for self-administered specialty injectables?
• What does the current self-injectable specialty drug market look like, who are the market leaders, and what will this market look like in 2022?
• What are the important therapeutic market segments for self-injectable specialty drugs, how large are they, and how fast are they growing?
• How important are pharma-device alliances and design partnerships in this market segment?
• What is the impact of economic, technology, and regulatory factors in this market?

 


Self Injectable Specialty Drugs – Summary of Contents

Executive Summary
Self-Injectable Specialty Drug Market Dynamics

Injectable Drug Demand Drivers
Drug Development Factors
Market Factors
Technology Factors
Self-Injection Product Design Factors
Ease-of-Use
Safety and Simplicity
Patient Interface
Competitive Landscape
Risks and Opportunities

Self-injectable Delivery Device Selection Criteria

Single vs Multi-Dose Devices
Fixed vs Variable Dosing
Lyophilized Drugs/Reconstitution
Disposable vs Reusable Devices
Human Engineering/Ergonomics
Branding/Private Labeling

Self-injectable Specialty Drugs – Device Categories
Autoinjectors
Needle-free Injectors
Pen Injectors
Prefilled Syringes
Wearable Injection Devices
Specialty Devices

Self-injectable Specialty Drugs – Product Analysis, Therapeutic
    Segment Assessments & Forecasts
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Blood Factors
Emergency Medicine
Hematopoietics
Hereditary Diseases
Hormone Replacement
Infectious Disease
Metabolic Diseases
– Glycemic Control
– Osteoporosis
Neurology
Oncology
– Hormones
– Immune Modulators
Reproductive Health
Vaccines

Company Profiles


Useful Links